This is in agreement with previous reports describing that specific RET SNPs may act as genetic modifiers in MTC, possibly affecting its susceptibility, progression, or phenotypic expression [56,57,58], although controversial data exist regarding this issue [59]. Here, RET is linked to medullary thyroid gland carcinoma.